CAR-T療法市場シェア分析と機会 2025-2031
CAR-T Therapy Market Report Analysis
CAR-T Therapy Market
-
CAGR (2025 - 2031)16.2% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis International AG
- Kite Pharma, Inc. (Gilead Sciences, Inc.)
- Juno Therapeutics (Celgene Corporation)
- Bluebird Bio, Inc. (Celgene Corporation)
- Sorrento Therapeutics Inc.
- Mustang Bio, Inc
- Aurora Biopharma Inc.
- Legend Biotech (Genscript Biotech Corporation)
- Pfizer, Inc.
Regional Overview
- 北米
- ヨーロッパ
- アジア太平洋
- 南米および中米
- 中東およびアフリカ
Market Segmentation
By 標的抗原
- CD 19
- BCMA
- HER2
- GD2
- CD 20
- CD22
- CD30
- CD33
- HER1など
By 治療応用
- 急性リンパ性白血病
- 慢性リンパ性白血病
- びまん性大細胞型B細胞リンパ腫
- 濾胞性リンパ腫
- 多発性骨髄腫
- 神経膠芽腫
- 肉腫
- 神経芽腫
- 急性骨髄性白血病
- 乳がん
- 膵臓がん
- 肝細胞がん
- 大腸がんなど
By 地理
- 北米
- ヨーロッパ
- アジア太平洋
- 南米
- 中米
- 中東
- アフリカ
Get Free Sample For